Operating Expenses Summary of Viveve Medical, Inc.

Viveve Medical, Inc.'s latest annual operating expenses in 2021 was 22.17 Million USD , up 18.0% from previous year.
Viveve Medical, Inc.'s latest quarterly operating expenses in 2022 Q3 was 5.2 Million USD , down -1.99% from previous quarter.
Viveve Medical, Inc. reported a annual operating expenses of 18.79 Million USD in annual operating expenses 2020, down -39.29% from previous year.
Viveve Medical, Inc. reported a annual operating expenses of 30.95 Million USD in annual operating expenses 2019, down -40.8% from previous year.
Viveve Medical, Inc. reported a quarterly operating expenses of 5.31 Million USD for 2022 Q2, down -8.27% from previous quarter.
Viveve Medical, Inc. reported a quarterly operating expenses of 5.79 Million USD for 2022 Q1, down -2.57% from previous quarter.

Annual Operating Expenses Chart of Viveve Medical, Inc. (2021 - 1990)

Historical Annual Operating Expenses of Viveve Medical, Inc. (2021 - 1990)

Year	Operating Expenses	Operating Expenses Growth
2021	22.17 Million USD	18.0%
2020	18.79 Million USD	-39.29%
2019	30.95 Million USD	-40.8%
2018	52.28 Million USD	26.99%
2017	41.17 Million USD	93.92%
2016	21.23 Million USD	70.52%
2015	12.45 Million USD	118.38%
2014	5.7 Million USD	4.68%
2013	5.44 Million USD	16.79%
2012	4.66 Million USD	27.54%
2011	3.65 Million USD	16.54%
2010	3.13 Million USD	-26.03%
2009	4.24 Million USD	-19.03%
2008	5.23 Million USD	-15.17%
2007	6.17 Million USD	76.16%
2006	3.5 Million USD	-42.39%
2005	6.08 Million USD	11.49%
2004	5.45 Million USD	27.64%
2003	4.27 Million USD	-5.27%
2002	4.51 Million USD	-45.88%
2001	8.34 Million USD	-43.45%
2000	14.75 Million USD	-2.34%
1999	15.1 Million USD	-29.42%
1998	21.4 Million USD	5.94%
1997	20.2 Million USD	83.64%
1996	11 Million USD	39.24%
1995	7.9 Million USD	41.07%
1994	5.6 Million USD	16.67%
1993	4.8 Million USD	26.32%
1992	3.8 Million USD	90.0%
1991	2 Million USD	1900.0%
1990	100 Thousand USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2022 Q3	5.2 Million USD	-1.99%
2022 Q2	5.31 Million USD	-8.27%
2022 Q1	5.79 Million USD	-2.57%
2021 Q2	5.11 Million USD	-7.28%
2021 Q3	5.6 Million USD	9.71%
2021 Q4	5.94 Million USD	6.06%
2021 FY	22.17 Million USD	18.0%
2021 Q1	5.51 Million USD	20.59%
2020 Q3	3.64 Million USD	-20.31%
2020 Q1	6 Million USD	-13.44%
2020 Q2	4.57 Million USD	-23.79%
2020 Q4	4.57 Million USD	25.38%
2020 FY	18.79 Million USD	-39.29%
2019 Q3	6.48 Million USD	-23.14%
2019 Q1	9.1 Million USD	-34.64%
2019 Q4	6.93 Million USD	6.99%
2019 Q2	8.43 Million USD	-7.4%
2019 FY	30.95 Million USD	-40.8%
2018 Q3	12.55 Million USD	-4.22%
2018 Q1	12.68 Million USD	3.98%
2018 Q2	13.1 Million USD	3.33%
2018 FY	52.28 Million USD	26.99%
2018 Q4	13.93 Million USD	10.97%
2017 Q1	7.83 Million USD	20.86%
2017 FY	41.17 Million USD	93.92%
2017 Q4	12.2 Million USD	12.63%
2017 Q3	10.83 Million USD	5.15%
2017 Q2	10.3 Million USD	31.44%
2016 Q3	5.32 Million USD	4.88%
2016 Q4	6.48 Million USD	21.76%
2016 Q1	4.34 Million USD	12.8%
2016 Q2	5.07 Million USD	16.9%
2016 FY	21.23 Million USD	70.52%
2015 Q2	2.9 Million USD	20.02%
2015 Q3	3.27 Million USD	12.56%
2015 Q1	2.42 Million USD	44.56%
2015 FY	12.45 Million USD	118.38%
2015 Q4	3.85 Million USD	17.7%
2014 Q3	2.36 Million USD	90.5%
2014 FY	5.7 Million USD	4.68%
2014 Q1	996 Thousand USD	-16.37%
2014 Q2	1.24 Million USD	24.5%
2014 Q4	1.67 Million USD	-29.07%
2013 Q3	1.49 Million USD	-1.9%
2013 Q1	1.23 Million USD	8.02%
2013 FY	5.44 Million USD	16.79%
2013 Q4	1.19 Million USD	-20.28%
2013 Q2	1.52 Million USD	22.92%
2012 Q3	1.22 Million USD	9.39%
2012 Q2	1.11 Million USD	-4.93%
2012 Q1	1.17 Million USD	8.09%
2012 FY	4.66 Million USD	27.54%
2012 Q4	1.14 Million USD	-6.21%
2011 Q4	1.08 Million USD	20.49%
2011 FY	3.65 Million USD	16.54%
2011 Q2	1.04 Million USD	-13.04%
2011 Q1	1.19 Million USD	153.39%
2011 Q3	903 Thousand USD	-13.17%
2010 FY	3.13 Million USD	-26.03%
2010 Q3	660 Thousand USD	-30.67%
2010 Q1	1.05 Million USD	7.44%
2010 Q2	952 Thousand USD	-9.68%
2010 Q4	472 Thousand USD	-28.48%
2009 Q3	882 Thousand USD	-17.18%
2009 Q1	1.31 Million USD	20.22%
2009 Q4	981 Thousand USD	11.22%
2009 FY	4.24 Million USD	-19.03%
2009 Q2	1.06 Million USD	-18.95%
2008 Q1	1.57 Million USD	0.32%
2008 FY	5.23 Million USD	-15.17%
2008 Q4	1.09 Million USD	-3.7%
2008 Q3	1.13 Million USD	-20.8%
2008 Q2	1.43 Million USD	-9.19%
2007 FY	6.17 Million USD	76.16%
2007 Q4	1.57 Million USD	7.23%
2007 Q2	1.63 Million USD	8.51%
2007 Q1	1.5 Million USD	38.87%
2007 Q3	1.46 Million USD	-10.11%
2006 Q2	1.26 Million USD	6742.11%
2006 FY	3.5 Million USD	-42.39%
2006 Q1	-19 Thousand USD	-101.23%
2006 Q4	1.08 Million USD	-8.22%
2006 Q3	1.18 Million USD	-6.5%
2005 FY	6.08 Million USD	11.49%
2005 Q4	1.54 Million USD	-0.58%
2005 Q3	1.54 Million USD	0.19%
2005 Q1	1.45 Million USD	37.41%
2005 Q2	1.54 Million USD	6.55%
2004 Q3	1.5 Million USD	8.68%
2004 Q2	1.38 Million USD	-9.02%
2004 Q1	1.51 Million USD	59.06%
2004 FY	5.45 Million USD	27.64%
2004 Q4	1.05 Million USD	-29.69%
2003 Q2	1.19 Million USD	8.93%
2003 FY	4.27 Million USD	-5.27%
2003 Q3	1.03 Million USD	-13.81%
2003 Q4	955 Thousand USD	-7.28%
2003 Q1	1.09 Million USD	3.49%
2002 Q4	1.06 Million USD	3.31%
2002 FY	4.51 Million USD	-45.88%
2002 Q3	1.02 Million USD	-11.63%
2002 Q2	1.16 Million USD	-8.44%
2002 Q1	1.26 Million USD	-5.02%
2001 Q4	1.33 Million USD	-37.82%
2001 Q3	2.14 Million USD	-10.17%
2001 Q2	2.39 Million USD	-3.24%
2001 Q1	2.47 Million USD	-44.28%
2001 FY	8.34 Million USD	-43.45%
2000 Q1	3.66 Million USD	-6.17%
2000 Q2	3.49 Million USD	-4.67%
2000 Q3	3.16 Million USD	-9.42%
2000 Q4	4.43 Million USD	40.15%
2000 FY	14.75 Million USD	-2.34%
1999 Q4	3.9 Million USD	34.62%
1999 Q3	2.9 Million USD	-27.5%
1999 Q2	4 Million USD	-6.98%
1999 Q1	4.3 Million USD	-24.56%
1999 FY	15.1 Million USD	-29.42%
1998 Q1	4.9 Million USD	-19.67%
1998 Q3	4.9 Million USD	-15.52%
1998 Q4	5.7 Million USD	16.33%
1998 FY	21.4 Million USD	5.94%
1998 Q2	5.8 Million USD	18.37%
1997 Q2	5 Million USD	16.28%
1997 Q3	4.8 Million USD	-4.0%
1997 FY	20.2 Million USD	83.64%
1997 Q1	4.3 Million USD	22.86%
1997 Q4	6.1 Million USD	27.08%
1996 Q1	2.5 Million USD	121.01%
1996 Q4	3.5 Million USD	29.63%
1996 Q3	2.7 Million USD	8.0%
1996 Q2	2.5 Million USD	0.0%
1996 FY	11 Million USD	39.24%
1995 Q2	- USD	0.0%
1995 Q3	- USD	0.0%
1995 Q4	-11.9 Million USD	0.0%
1995 Q1	- USD	-100.0%
1995 FY	7.9 Million USD	41.07%
1994 Q1	1.5 Million USD	15.38%
1994 FY	5.6 Million USD	16.67%
1994 Q3	1.4 Million USD	16.67%
1994 Q4	1.6 Million USD	14.29%
1994 Q2	1.2 Million USD	-20.0%
1993 Q4	1.3 Million USD	18.18%
1993 FY	4.8 Million USD	26.32%
1993 Q1	1.1 Million USD	0.0%
1993 Q2	1.3 Million USD	18.18%
1993 Q3	1.1 Million USD	-15.38%
1992 Q4	1.1 Million USD	22.22%
1992 Q1	800 Thousand USD	140.0%
1992 Q3	900 Thousand USD	-18.18%
1992 Q2	1.1 Million USD	37.5%
1992 FY	3.8 Million USD	90.0%
1991 Q4	-2 Million USD	0.0%
1991 Q2	- USD	0.0%
1991 Q3	- USD	0.0%
1991 Q1	- USD	100.0%
1991 FY	2 Million USD	1900.0%
1990 FY	100 Thousand USD	0.0%
1990 Q3	- USD	0.0%
1990 Q2	- USD	0.0%
1990 Q1	- USD	0.0%
1990 Q4	-100 Thousand USD	0.0%

Peer Operating Expenses Comparison of Viveve Medical, Inc.

Name	Operating Expenses	Operating Expenses Difference
Acutus Medical, Inc.	11.22 Million USD	-97.55%
Biotricity, Inc.	17.18 Million USD	-29.029%
Cell MedX Corp.	313.43 Thousand USD	-6974.307%
Dynatronics Corporation	9.9 Million USD	-123.788%
Nemaura Medical Inc.	7.13 Million USD	-210.598%
PetVivo Holdings, Inc.	11.36 Million USD	-95.17%
RetinalGenix Technologies Inc.	2.08 Million USD	-962.409%
Sonendo, Inc.	68.46 Million USD	67.614%
Telesis Bio, Inc.	63.48 Million USD	65.076%
Talis Biomedical Corporation	67.18 Million USD	66.998%

Global Stocks Search

Viveve Medical, Inc. (VIVE)

Operating Expenses Summary of Viveve Medical, Inc.

Annual Operating Expenses Chart of Viveve Medical, Inc. (2021 - 1990)

Historical Annual Operating Expenses of Viveve Medical, Inc. (2021 - 1990)

Peer Operating Expenses Comparison of Viveve Medical, Inc.